Adhera Therapeutics, Inc. (ATRX)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - - - 252 Thousand 76.18 Thousand -
Cost of Revenue - - - 409 Thousand 458.7 Thousand 450.9 Thousand
Gross Profit - - - -157 Thousand -382.52 Thousand -450.9 Thousand
Operating Expenses 1.61 Million 674 Thousand 2.03 Million 10.04 Million 10.23 Million 6.09 Million
Selling, General and Administrative Expenses 1.61 Million 674 Thousand 2.03 Million 9.97 Million 9.66 Million 4.73 Million
Research and Development Expenses - - - - 240.98 Thousand 907.49 Thousand
Other Expenses - -141 Thousand 45 Thousand 70 Thousand -810.21 Thousand 450.9 Thousand
Cost and Expenses 1.61 Million 674 Thousand 2.03 Million 10.45 Million 10.69 Million 6.09 Million
Operating Income -1.61 Million -674 Thousand -2.03 Million -11.31 Million -15.79 Million -6.09 Million
Interest Expense 3.15 Million 1.43 Million 1.77 Million 662 Thousand 149.9 Thousand 127.93 Thousand
Income Tax Expense - 1.43 Million 1.77 Million 662 Thousand 5.17 Million 800.00
Earnings before Tax -2.11 Million -6.35 Million -3.76 Million -11.97 Million -16.75 Million -6.21 Million
Net Income -2.11 Million -7.78 Million -5.54 Million -12.64 Million -16.75 Million -6.21 Million
Earnings Per Share Basic -1.18 -11.97 -10.19 -23.32 -30.92 -12.65
Earnings Per Share Diluted -1.18 -11.97 -10.19 -23.32 -30.92 -12.65
Weighted Average Shares Outstanding 2.3 Million 650.18 Thousand 543.82 Thousand 542.04 Thousand 541.93 Thousand 491.8 Thousand
Weighted Average Shares Outstanding (Diluted) 2.3 Million 650.18 Thousand 543.82 Thousand 542.04 Thousand 541.93 Thousand 491.8 Thousand
Gross Margin - - - -0.62 -5.02 -
EBIT Margin - - - -40.15 -145.65 -
Profit Margin - - - -50.16 -219.92 -
EBITDA - - -1.99 Million -11.23 Million -16.27 Million -5.63 Million
Earnings Before Tax Margin - - - -44.90 -207.32 -

Income Statement Charts